Genetics and epigenetics of parathyroid hormone resistance

Endocrine Development

Volumn 24, Issue , 2013, Pages 11-24

  Bastepe, Murat ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CELL SURFACE RECEPTOR; CIS ACTING ELEMENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GENOMIC DNA; GONADOTROPIN; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE DERIVATIVE; NEUROTRANSMITTER; PARATHYROID HORMONE; PHOSPHATE; SECRETORY PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; SYNTAXIN 16; THYROTROPIN; TRANS ACTING FACTOR; VASOPRESSIN;

ALBRIGHT SYNDROME; ALPHA CHAIN; ARTICLE; BONE DYSPLASIA; CALCIUM EXCRETION; CLINICAL FEATURE; EPIGENETICS; ERYTHROCYTE; EXTRACHROMOSOMAL INHERITANCE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETICS; GENOME IMPRINTING; HAPLOINSUFFICIENCY; HORMONE RESISTANCE; HUMAN; KIDNEY PROXIMAL TUBULE; LINKAGE ANALYSIS; NONHUMAN; PARATHYROID HORMONE RESISTANCE; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; PSEUDOHYPOPARATHYROIDISM TYPE 1; PSEUDOHYPOPARATHYROIDISM TYPE 2; URINARY EXCRETION;

EID: 84875450957     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000342494     Document Type: Article

References (100)

1. Albright F, Burnett CH, Smith PH, Parson W: Pseudohypoparathyroidism-an example of 'Seabright-Bantam syndrome'. Endocrinology 1942;30:922-932.
2. Chase LR, Melson GL, Aurbach GD: Pseudohypoparathyroidism: defective excretion of 3 ,5 -AMP in response to parathyroid hormone. J Clin Invest 1969;48:1832-1844.
3. Drezner M, Neelon FA, Lebovitz HE: Pseudohypoparathyroidism type II: a possible defect in the reception of the cyclic AMP signal. N Engl J Med 1973;289:1056-1060.
4. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM: Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983;74:545-556.
5. Mallet E, Carayon P, Amr S, Brunelle P, Ducastelle T, Basuyau JP, de Menibus CH: Coupling defect of thyrotropin receptor and adenylate cyclase in a pseudohypoparathyroid patient. J Clin Endocrinol Metab 1982;54:1028-1032.
6. Wolfsdorf JI, Rosenfield RL, Fang VS, Kobayashi R, Razdan AK, Kim MH: Partial gonadotrophinresistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh) 1978;88:321-328.
7. Stirling HF, Barr DGD, Kelnar CJH: Familial growth hormone releasing factor deficiency in pseudohypoparathyroidism. Arch Dis Child 1991; 66:533-535.
8. Namnoum AB, Merriam GR, Moses AM, Levine MA: Reproductive dysfunction in women with Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 1998;83:824-829.
9. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A: Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 2003;88:4070-4074.
10. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA: Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003;88:4059-4069.
11. Weinstein LS, Gejman PV, Friedman E, Kadowaki T, Collins RM, Gershon ES, Spiegel AM: Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1990;87: 8287-8290.
12. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA: Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 1990;322:1412-1419.
13. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y: Isolation and characterization of the human Gsα gene. Proc Natl Acad Sci USA 1988;85:2081-2085.
14. Gejman PV, Weinstein LS, Martinez M, Spiegel AM, Cao Q, Hsieh WT, Hoehe MR, Gershon ES: Genetic mapping of the Gs-alpha subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics 1991;9:782-783.
15. Rao VV, Schnittger S, Hansmann I: G protein Gs alpha (GNAS 1), the probable candidate gene for Albright hereditary osteodystrophy, is assigned to human chromosome 20q12-q13.2. Genomics 1991; 10:257-261.
16. Levine MA, Modi WS, O'Brien SJ: Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2 → q13.3 in human by in situ hybridization. Genomics 1991;11:478-479.
17. Gilman AG: G proteins: Transducers of receptorgenerated signals. Ann Rev Biochem 1987;56:615-649.
18. Spiegel AM: Introduction to G-protein-coupled signal transduction and human disease. In: AM Spiegel (ed), G Proteins, Receptors, and Disease. Humana Press, Totowa, 1998, pp 1-21.
19. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE: Insights into G protein structure, function, and regulation. Endocr Rev 2003;24:765-781.
20. Moses AM, Weinstock RS, Levine MA, Breslau NA: Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism. J Clin Endocrinol Metab 1986;62:221-224.
21. Weinstein LS: Albright hereditary osteodystrophy, pseudohypoparathyroidism, and Gs deficiency. In: AM Spiegel (ed), G Proteins, Receptors, and Disease. Humana Press, Totowa, 1998, pp. 23-56.
22. Levine MA: Pseudohypoparathyroidism: from bedside to bench and back. J Bone Miner Res 1999;14: 1255-1260.
23. Albright F, Forbes AP, Henneman PH: Pseudopseudohypoparathyroidism. Trans Assoc Am Physicians 1952;65:337-350.
24. Davies AJ, Hughes HE: Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993;30: 101-103.
25. Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria Z, Accili D, Westphal H, Weinstein LS: Variable and tissue-specific hormone resistance in heterotrimeric Gs protein α-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the Gsα gene. Proc Natl Acad Sci USA 1998;95:8715-8720.
26. Weinstein LS, Yu S, Ecelbarger CA: Variable imprinting of the heterotrimeric G protein G(s) alpha-subunit within different segments of the nephron. Am J Physiol Renal Physiol 2000;278: F507-F5 14.
27. Liu J, Erlichman B, Weinstein LS: The stimulatory G protein α-subunit Gsα is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metabol 2003;88:4336-43 41.
28. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A: The Gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002;87: 4736-4740.
29. Germain-Lee EL, Ding CL, Deng Z, Crane JL, Saji M, Ringel MD, Levine MA: Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002;296:67-72.
30. Hayward B, Barlier A, Korbonits M, Grossman A, Jacquet P, Enjalbert A, Bonthron D: Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001;107:R31-R3 6.
31. Chen M, Wang J, Dickerson KE, Kelleher J, Xie T, Gupta D, Lai EW, Pacak K, Gavrilova O, Weinstein LS: Central nervous system imprinting of the G protein G(s)alpha and its role in metabolic regulation. Cell Metab 2009;9:548-5 55.
32. Hayward B, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bronthon DT: The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998;95:10038-10043.
33. Hayward BE, Moran V, Strain L, Bonthron DT: Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998; 95:15475-15480.
34. Campbell R, Gosden CM, Bonthron DT: Parental origin of transcription from the human GNAS1 gene. J Med Genet 1994;31:607-614.
35. Peters J, Wroe SF, Wells CA, Miller HJ, Bodle D, Beechey CV, Williamson CM, Kelsey G: A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA 1999;96:3830-3835.
36. Mantovani G, Bondioni S, Locatelli M, Pedroni C, Lania AG, Ferrante E, Filopanti M, Beck-Peccoz P, Spada A: Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J Clin Endocrinol Metab 2004;89:6316-631 9.
37. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Jüppner H, Kronenberg HM, Chung UI: Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci USA 2004;101:14794-14799.
38. Long DN, McGuire S, Levine MA, Weinstein LS, Germain-Lee EL: Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab 2007;92: 1073-107 9.
39. Mouallem M, Shaharabany M, Weintrob N, Shalitin S, Nagelberg N, Shapira H, Zadik Z, Farfel Z: Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudo-hypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf) 2008;68:233-239.
40. Levine MA, Jap TS, Mauseth RS, Downs J, Spiegel AM: Activity of the stimulatory guanine nucleotidebinding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986;62:497-502.
41. Miric A, Vechio JD, Levine MA: Heterogeneous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1993;76:1560-156 8.
42. Farfel Z, Bourne HR: Deficient activity of recept orcyclase coupling protein in platelets of patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 1980;51:1202-120 4.
43. Farfel Z, Brothers VM, Brickman AS, Conte F, Neer R, Bourne HR: Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity. Proc Natl Acad Sci USA1981;78:3098-3 102.
44. Bourne HR, Kaslow HR, Brickman AS, Farfel Z: Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein. J Clin Endocrinol Metab 1981;53:636-6 40.
45. Spiegel AM, Levine MA, Aurbach GD, Downs RW, Jr, Marx SJ, Lasker RD, Moses AM, Breslau NA: Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism. Am J Physiol 1982;243: E37-E 42.
46. Motulsky HJ, Hughes RJ, Brickman AS, Farfel Z, Bourne HR, Insel PA: Platelets of pseudohypoparathyroid patients: evidence that distinct receptorcyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase. Proc Natl Acad Sci USA 1982;79:4193-419 7.
47. Farfel Z, Abood ME, Brickman AS, Bourne HR: Deficient activity of receptor-cyclase coupling protein is transformed lymphoblasts of patients with pseudohypoparathyroidism, type I. J Clin Endocrinol Metab 1982;55:113-11 7.
48. Levine MA, Eil C, Downs RW Jr, Spiegel AM: Deficient guanine nucleotide regulatory unit activity in cultured fibroblast membranes from patients with pseudohypoparathyroidism type I. A cause of impaired synthesis of 3',5'-cyclic AMP by intact and broken cells. J Clin Invest 1983;72:316-3 24.
49. Levine MA, Ahn TG, Klupt SF, Kaufman KD, Smallwood PM, Bourne HR, Sullivan KA, Van Dop C: Genetic deficiency of the alpha subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 1988;85:617-6 21.
50. Patten JL, Levine MA: Immunochemical analysis of the α-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 1990;71: 1208-1214.
51. Carter A, Bardin C, Collins R, Simons C, Bray P, Spiegel A: Reduced expression of multiple forms of the ααsubunit of the stimulatory GTP-binding protein in pseudohypoparathyroidism type Ia. Proc Natl Acad Sci USA 1987;84:7266-7269.
52. Levine MA, Downs RW Jr, Singer M, Marx SJ, Aurbach GD, Spiegel AM: Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 1980;94:1319-1324.
53. Linglart A, Carel JC, Garabedian M, Le T, Mallet E, Kottler ML: GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab 2002; 87:189-1 97.
54. Thiele S, de Sanctis L, Werner R, Grotzinger J, Aydin C, Juppner H, Bastepe M, Hiort O: Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsalpha-receptor interaction. Hum Mutat 2011;32:653-6 60.
55. Linglart A, Mahon MJ, Kerachian MA, Berlach DM, Hendy GN, Jüppner H, Bastepe M: Coding GNAS mutations leading to hormone resistance impair in vitro agonist-and cholera toxin-induced adenosine cyclic 3 ,5 -monophosphate formation mediated by human XLαs. Endocrinology 2006; 147:2253-22 62.
56. Peterman MG, Garvey JL: Pseudohypoparathyroidism; case report. Pediatrics 1949;4:790.
57. Reynolds TB, Jacobson G, Edmondson HA, Martin HE, Nelson CH: Pseudohypoparathyroidism: report of a case showing bony demineralization. J Clin Endocrinol Metab 1952;12:560.
58. Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Jüppner H: Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 2001;10:1231-1241.
59. Bastepe M, Lane AH, Jüppner H: Paternal uniparental isodisomy of chromosome 20q (patUPD20q)-and the resulting changes in GNAS1 methylation-as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 2001;68:1283-1289.
60. Mantovani G, Bondioni S, Linglart A, Maghnie M, Cisternino M, Corbetta S, Lania AG, Beck-Peccoz P, Spada A: Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2007;92:3738-37 42.
61. Wu WI, Schwindinger WF, Aparicio LF, Levine MA: Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of Gαs: a cause of pseudohypoparathyroidism type Ib. J Biol Chem 2001;276:165-171.
62. Jüppner H, Schipani E, Bastepe M, Cole DEC, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR, Vikkula M: The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 1998;95:11798-11803.
63. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R: Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997;272:11657-11662.
64. Kehlenbach RH, Matthey J, Huttner WB: XLαs is a new type of G protein. Nature 1994;372:804-809, erratum Nature 1995;375:253.
65. Swaroop A, Agarwal N, Gruen JR, Bick D, Weissman SM: Differential expression of novel Gs alpha signal transduction protein cDNA species. Nucleic Acids Res 1991;19:4725-4729.
66. Ishikawa Y, Bianchi C, Nadal-Ginard B, Homcy CJ: Alternative promoter and 5 exon generate a novel Gsα mRNA. J Biol Chem 1990;265:8458-8462.
67. Hayward B, Bonthron D: An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 2000;9:835-841.
68. Wroe SF, Kelsey G, Skinner JA, Bodle D, Ball ST, Beechey CV, Peters J, Williamson CM: An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci USA 2000;97:3342-3346.
69. Liu J, Yu S, Litman D, Chen W, Weinstein L: Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 2000;20:5808-5817.
70. Liu J, Litman D, Rosenberg M, Yu S, Biesecker L, Weinstein L: A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 2000;106:1167-1174.
71. Bastepe M, Fröhlich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Körkkö J, Nakamoto JM, Rosenbloom AL, Slyper AH, Sugimoto T, Tsatsoulis A, Crawford JD, Jüppner H: Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 2003;112:1255-1263.
72. Linglart A, Gensure RC, Olney RC, Jüppner H, Bastepe M: A Novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 2005; 76:804-8 14.
73. Fröhlich LF, Bastepe M, Ozturk D, Abu-Zahra H, Jüppner H: Lack of Gnas epigenetic changes and pseudohypoparathyroidism type Ib in mice with targeted disruption of syntaxin-16. Endocrinology 2007;148:2925-29 35.
74. Bastepe M, Fröhlich LF, Linglart A, Abu-zahra HS, Tojo K, Ward LM, Jüppner H: Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type-Ib. Nat Genet 2005;37:25-37.
75. Fröhlich LF, Mrakovcic M, Steinborn R, Chung UI, Bastepe M, Juppner H: Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib. Proc Natl Acad Sci USA 2010;107:9275-9280.
76. Fernandez-Rebollo E, Maeda A, Reyes M, Turan S, Frohlich LF, Plagge A, Kelsey G, Juppner H, Bastepe M: Loss of XLalphas (extra-large alphas) imprinting results in early postnatal hypoglycemia and lethality in a mouse model of pseudohypoparathyroidism Ib. Proc Natl Acad Sci USA 2012;109:6638-66 43.
77. Chillambhi S, Turan S, Hwang DY, Chen HC, Juppner H, Bastepe M: Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J Clin Endocrinol Metab 2010;95:3993-4002.
78. Chotalia M, Smallwood SA, Ruf N, Dawson C, Lucifero D, Frontera M, James K, Dean W, Kelsey G: Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev 2009;23:105-117.
79. Richard N, Abeguile G, Coudray N, Mittre H, Gruchy N, Andrieux J, Cathebras P, Kottler ML: A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2012;97:E863-E867.
80. Williamson CM, Turner MD, Ball ST, Nottingham WT, Glenister P, Fray M, Tymowska-Lalanne Z, Plagge A, Powles-Glover N, Kelsey G, Maconochie M, Peters J: Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster. Nat Genet 2006;38:350-355.
81. Linglart A, Bastepe M, Jüppner H: Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol (Oxf) 2007;67:822-831.
82. Maupetit-Mehouas S, Mariot V, Reynes C, Bertrand G, Feillet F, Carel JC, Simon D, Bihan H, Gajdos V, Devouge E, Shenoy S, Agbo-Kpati P, Ronan A, Naud-Saudreau C, Lienhardt A, Silve C, Linglart A: Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. J Med Genet 2011;48:55-63.
83. Liu J, Nealon JG, Weinstein LS: Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 2005;14:95-102.
84. Bastepe M, Altug-Teber O, Agarwal C, Oberfield SE, Bonin M, Jüppner H: Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone 2011;48:659-6 62.
85. Lecumberri B, Fernandez-Rebollo E, Sentchordi L, Saavedra P, Bernal-Chico A, Pallardo LF, Jimenez Bustos JM, Castano L, De Santiago M, Hiort O, Perez de Nanclares G, Bastepe M: Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gsα coding mutations and GNAS imprinting defects. J Med Genet 2010;47:276-2 80.
86. Fernandez-Rebollo E, Lecumberri B, Garin I, Arroyo J, Bernal-Chico A, Goni F, Orduna R, Castano L, Perez de Nanclares G: New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol 2010; 163:953-9 62.
87. Fernandez-Rebollo E, Perez de Nanclares G, Lecumberri B, Turan S, Anda E, Perez-Nanclares G, Feig D, Nik-Zainal S, Bastepe M, Juppner H: Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 2011;26:1854-18 63.
88. Judson H, Hayward BE, Sheridan E, Bonthron DT: A global disorder of imprinting in the human female germ line. Nature 2002;416:539-542.
89. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S, Rouleau GA, Slim R: Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 2006; 38:300-30 2.
90. Mackay DJ, Callaway JL, Marks SM, White HE, Acerini CL, Boonen SE, Dayanikli P, Firth HV, Goodship JA, Haemers AP, Hahnemann JM, Kordonouri O, Masoud AF, Oestergaard E, Storr J, Ellard S, Hattersley AT, Robinson DO, Temple IK: Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57. Nat Genet 2008; 40:949-951.
91. de Nanclares GP, Fernandez-Rebollo E, Santin I, Garcia-Cuartero B, Gaztambide S, Menendez E, Morales MJ, Pombo M, Bilbao JR, Barros F, Zazo N, Ahrens W, Jüppner H, Hiort O, Castano L, Bastepe M: Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2007;92:2370-2373.
92. Mariot V, Maupetit-Mehouas S, Sinding C, Kottler ML, Linglart A: A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab 2008; 93:661-66 5.
93. Unluturk U, Harmanci A, Babaoglu M, Yasar U, Varli K, Bastepe M, Bayraktar M: Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am J Med Sci 2008;336:84-90.
94. Mantovani G, de Sanctis L, Barbieri AM, Elli FM, Bollati V, Vaira V, Labarile P, Bondioni S, Peverelli E, Lania AG, Beck-Peccoz P, Spada A: Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 2010;95:651-65 8.
95. Klenke S, Siffert W, Frey UH: A novel aspect of GNAS imprinting: higher maternal expression of Galphas in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol Cell Endocrinol 2011;341:63-70.
96. Zazo C, Thiele S, Martin C, Fernandez-Rebollo E, Martinez-Indart L, Werner R, Garin I, Hiort O, Perez de Nanclares G: Gsalpha activity is reduced in erythrocyte membranes of patients with pseudohypoparathyroidism due to epigenetic alterations at the GNAS locus. J Bone Miner Res 2011;26: 1864-1870.
97. Fernandez-Rebollo E, Garcia-Cuartero B, Garin I, Largo C, Martinez F, Garcia-Lacalle C, Castano L, Bastepe M, Perez de Nanclares G: Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab 2010;95:765-771.
98. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, Motte E, Pinto G, Chanson P, Bougneres P, Clauser E, Silve C: Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 2011;364:2218-2226.
99. Lee H, Graham JM Jr, Rimoin DL, Lachman RS, Krejci P, Tompson SW, Nelson SF, Krakow D, Cohn DH: Exome sequencing identifies PDE4D mutations in acrodysostosis. Am J Hum Genet 2012; 90:746-7 51.
100. Michot C, Le Goff C, Goldenberg A, Abhyankar A, Klein C, Kinning E, Guerrot AM, Flahaut P, Duncombe A, Baujat G, Lyonnet S, Thalassinos C, Nitschke P, Casanova JL, Le Merrer M, Munnich A, Cormier-Daire V: Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am J Hum Genet 2012;90:740-74 5.